XY (Hong Kong) Medical Technology Co., Limited
About us
Founded in 2019, Xun Yuan Clinical Quality Oversight is dedicated to empowering global pharmaceutical, medical device, and IVD sponsors with global regulation-aligned quality solutions in Greater China. As your trusted “authorized delegate,” we bridge the gap between global compliance standards and local regulatory realities – delivering efficiency, integrity, and peace of mind.
Pain Point
01
'Scaling in Greater China is costly'
Building in-house oversight teams drains resources with limited ROI.
02
'Local compliance is fragmented'
Navigating China’s pharma/device regulations alongside global standards is overwhelming.
03
'Oversight independence is compromised'
Generic CROs lack conflict-free focus on your study integrity.
高效能源管理系统
Efficient energy management system
智能驾驶辅助功能
Intelligent driver assistance system
轻量化车身设计
Lightweight body design
Solution
XY (Hong Kong) Medical Technology Co., Limited
About us
Founded in 2019, Xun Yuan Clinical Quality Oversight is dedicated to empowering global pharmaceutical, medical device, and IVD sponsors with global regulation-aligned quality solutions in Greater China. As your trusted “authorized delegate,” we bridge the gap between global compliance standards and local regulatory realities – delivering efficiency, integrity, and peace of mind.
On-Demand Quality Oversight
Tailored to the sponsor responsibilities of global Regulation requirement
On-Demand Quality Oversight
Tailored to the sponsor responsibilities of global Regulation requirement
Local Regulatory Mastery
Decades of expertise in China’s site/CRO ecosystem
Local Regulatory Mastery
Decades of expertise in China’s site/CRO ecosystem
Authorized Delegate Service
Act as your extension to ensure end-to-end compliance
Authorized Delegate Service
Act as your extension to ensure end-to-end compliance
Pain Point
Card1
'Scaling in Greater China is costly' – Building in-house oversight teams drains resources with limited ROI.
Card2
'Local compliance is fragmented' – Navigating China’s pharma/device regulations alongside global standards is overwhelming.
Card3
'Oversight independence is compromised' – Generic CROs lack conflict-free focus on your study integrity.
Why Xun Yuan
Zero Turnover (2019+)
10+ Years Avg. Expert Experience
2-Week Rapid
Deployment
Conflict-Free
Solution
Global Pharma Director, Oncology
“Xun Yuan’s authorized delegate support turned our China compliance challenges into a competitive advantage. Their local insights ensured seamless Global Regulation alignment – no delays, no surprises.”
News information
-
Interpretation of the New Intellectual Property Protection Policy in 2024
Currently, global scientific and technological innovation is entering an unprecedented period of intense activity. A new round of technological revolution and industrial transformation is reshaping the global innovation landscape, and the importance of strengthening the coordinated development of standards and patents, two strategic innovation resources, is becoming increasingly prominent.
-
International Patent Application Strategy Guide
As a product of the deep integration of standards and patents, standard-essential patents have become a strategic element of concern to international organizations and major countries (regions) around the world, and are also the focus of competition in key technologies, markets and industries.
-
Copyright protection in the digital age
The report is aimed at government departments, social organizations, universities, research institutions, enterprises, and personnel engaged in standard essential patents. It mainly reviews and analyzes important domestic and foreign policies, related cases and data on standard essential patents in recent years, aiming to comprehensively, systematically and objectively present the overall development trend of standard essential patents.
-
Copyright protection in the digital age
The report is aimed at government departments, social organizations, universities, research institutions, enterprises, and personnel engaged in standard essential patents. It mainly reviews and analyzes important domestic and foreign policies, related cases and data on standard essential patents in recent years, aiming to comprehensively, systematically and objectively present the overall development trend of standard essential patents.
-
International Patent Application Strategy Guide
As a product of the deep integration of standards and patents, standard-essential patents have become a strategic element of concern to international organizations and major countries (regions) around the world, and are also the focus of competition in key technologies, markets and industries.
-
Interpretation of the New Intellectual Property Protection Policy in 2024
Currently, global scientific and technological innovation is entering an unprecedented period of intense activity. A new round of technological revolution and industrial transformation is reshaping the global innovation landscape, and the importance of strengthening the coordinated development of standards and patents, two strategic innovation resources, is becoming increasingly prominent.
Ready to Simplify Your Greater China Trials?
we anticipate risks and protect your study integrity
Ready to Simplify Your Greater China Trials?
点击右上角
分享给朋友吧
Copyright ©2025 All Rights Reserved XY (Hong Kong) Medical Technology Co., Limited
Phone:
+86-131 6214 3134
Email:
info@j-mednudge.com
Working hours:
GMT+8 | Mon-Fri 9:00-18:00
Phone:+86-131 6214 3134
Email: info@j-mednudge.com
Working hours:GMT+8 | Mon-Fri 9:00-18:00
点击右上角
分享给朋友吧
Copyright ©2025 All Rights Reserved XY (Hong Kong) Medical Technology Co., Limited
